Septerna is on a mission to make the promise of future GPCR medicines a reality for patients. Combining the latest advances in biochemical, structural and computational drug discovery approaches, we have built an industrialized platform to precisely control and modulate GPCR biology and pharmacology to discover and develop new high-impact medicines. With our Native Complex Platform™, we are opening a new frontier in GPCR small molecule discovery technologies to expand the druggable GPCR landscape.
We are always looking for talented scientists, drug hunters, and business professionals to join our mission to launch a new era of GPCR medicines. If you’re passionate about innovation, energized by teamwork, and fueled by the desire to change patient lives, join us and become a part of the Septerna story!
Company Details
- Employees
- 108
- Address
- 250 E Grand Ave,
- Industry
- Biotechnology
- Website
- http://www.septerna.com
- Keywords
- Concord.
- HQ
- South San Francisco, California
Septerna Questions
Septerna's website is http://www.septerna.com
Septerna's LinkedIn profile is https://www.linkedin.com/company/septernainc
Septerna has
108 employees.
View email and phone details for 108
employees at Septerna.
Septerna's industry is
Biotechnology
Septerna's top competitors are
Azurbio Pharma,
Kailera Therapeutics,
Trevena, Inc.,
Divert,
Aktis Oncology,
Triveni Bio,
Monopar Therapeutics Inc.,
Editas Medicine,
Novo Nordisk,
Seaport Therapeutics.
Septerna's categories are Biotechnology
